We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$1.54B
AUM Growth
+$81.9M
(+5.6%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
1.69%
Top 10 Holdings %
Top 10 Hldgs %
19.93%
Holding
435
New
22
Increased
147
Reduced
184
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$4.9M |
| 2 |
Walt Disney
DIS
|
+$3.71M |
| 3 |
Adobe
ADBE
|
+$3.68M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$3.35M |
| 5 |
Chevron
CVX
|
+$2.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$4.12M |
| 2 |
Wells Fargo
WFC
|
+$3.08M |
| 3 |
XYZ
Block Inc
XYZ
|
+$2.83M |
| 4 |
AABA
Altaba Inc
AABA
|
+$2.12M |
| 5 |
Northrop Grumman
NOC
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.5% |
| 2 | Technology | 12.42% |
| 3 | Industrials | 12.07% |
| 4 | Healthcare | 9.17% |
| 5 | Consumer Discretionary | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$188B
| $15.8M | 1.03% |
120,514
-502
| -0.4% | -$64.4K |
|
27
ExxonMobil
XOM
$662B
| $15.8M | 1.02% |
205,542
-20,035
| -9% | -$1.55M |
|
28
Rockwell Automation
ROK
$48.3B
| $14.9M | 0.97% |
90,864
+1,603
| +2% | +$271K |
|
|
ANSS
29
DELISTED
Ansys
ANSS
| $13.7M | 0.89% |
67,004
-602
| -0.9% | -$115K |
|
30
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $13.6M | 0.89% |
38,384
+2,006
| +6% | +$701K |
|
31
Visa
V
$675B
| $13.3M | 0.87% |
76,824
-386
| -0.5% | -$63.2K |
|
32
Honeywell
HON
$77B
| $12.9M | 0.84% |
78,305
+116
| +0.1% | +$18.5K |
|
33
Union Pacific
UNP
$174B
| $12.7M | 0.83% |
75,181
+3,426
| +5% | +$587K |
|
34
Amgen
AMGN
$226B
| $12.7M | 0.83% |
68,910
-2,169
| -3% | -$388K |
|
35
Lockheed Martin
LMT
$139B
| $12.5M | 0.81% |
34,468
-244
| -0.7% | -$81.6K |
|
36
Stryker
SYK
$133B
| $11.9M | 0.77% |
57,850
+2,096
| +4% | +$400K |
|
37
Church & Dwight Co
CHD
$24.5B
| $11.6M | 0.76% |
159,191
-4,435
| -3% | -$330K |
|
38
Pfizer
PFE
$154B
| $11.5M | 0.75% |
280,601
+3,460
| +1% | +$137K |
|
39
Lowe's Companies
LOW
$123B
| $11.3M | 0.74% |
112,469
+1,622
| +1% | +$171K |
|
|
SCHW
40
Charles Schwab
SCHW
$188B
| $11.2M | 0.73% |
277,942
+6,020
| +2% | +$262K |
|
41
McCormick & Company Non-Voting
MKC
$14.3B
| $10.8M | 0.7% |
139,824
-6,164
| -4% | -$475K |
|
42
Intel
INTC
$492B
| $10.8M | 0.7% |
224,836
+19,438
| +9% | +$964K |
|
43
TJX Companies
TJX
$175B
| $10.7M | 0.7% |
202,296
+11,414
| +6% | +$607K |
|
44
Mettler-Toledo International
MTD
$28.6B
| $10.5M | 0.68% |
12,489
+522
| +4% | +$394K |
|
|
45
Chevron
CVX
$382B
| $9.53M | 0.62% |
76,549
+21,395
| +39% | +$2.59M |
|
|
DNKN
46
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $9.44M | 0.61% |
118,468
+1,341
| +1% | +$102K |
|
47
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $9.27M | 0.6% |
105,672
+6,617
| +7% | +$564K |
|
|
PRAH
48
DELISTED
PRA Health Sciences, Inc.
PRAH
| $9.17M | 0.6% |
92,502
+23,983
| +35% | +$2.29M |
|
49
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $9.15M | 0.6% |
98,804
+7,078
| +8% | +$636K |
|
50
Phillips 66
PSX
$86B
| $8.78M | 0.57% |
93,900
-17,718
| -16% | -$1.59M |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
FFB
Carnegie Investment Counsel's Q2 2019 Portfolio in Review
As of Q2 2019, Carnegie Investment Counsel held 435 positions worth $1.54B, up 5.6% from $1.46B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Carnegie Investment Counsel's Q2 2019 filing shows 22 new, 147 increased, 184 reduced and 13 closed positions. Its largest new stake was Dow Inc: 46,030 shares worth $2.27M. The largest sale was DuPont de Nemours, an estimated $4.12M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
- Carnegie Investment Counsel's largest Q2 2019 buy was Dow Inc: 46,030 shares worth $2.27M.
- Carnegie Investment Counsel added most to Progressive in Q2 2019, an estimated $4.9M increase.
- Carnegie Investment Counsel's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $4.12M.
- Carnegie Investment Counsel fully exited Altaba Inc in Q2 2019, selling an estimated $2.12M.
- Carnegie Investment Counsel's ten largest holdings make up 20% of its $1.54B portfolio in Q2 2019.
- Carnegie Investment Counsel opened 22 new positions and closed 13 in Q2 2019.
- Carnegie Investment Counsel's portfolio value rose 5.6% quarter-over-quarter to $1.54B.
Based on Carnegie Investment Counsel's 13F filing for Q2 2019, filed 24 Jul 2019.